Related Experiment Video
Updated: Aug 3, 2026
A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Partial nonstructural 3 region analysis of hepatitis C virus genotype 3a
Anusorn Kiattanaphon1, Yaovaluk Vipsoongnern2, Duangkamol Kunthalert1
1Department of Microbiology and Parasitology, Faculty of Medical Science, Naresuan University, Phitsanulok, Thailand.
Insights
Hepatitis C virus (HCV) genotype 3a mutations in the NS3 gene are common, particularly at positions 168, 170, 174, and 175. This finding aids in developing new direct-acting antiviral drugs for HCV treatment.
Area of Science:
- Virology
- Molecular Biology
- Drug Discovery
Background:
- Hepatitis C virus (HCV) infection remains a global health concern.
- HCV genotype 3a is prevalent in Thailand, necessitating targeted treatment strategies.
- Direct-acting antivirals (DAAs) target HCV NS3, NS5A, and NS5b proteins, but resistance mutations emerge.
Purpose of the Study:
- To analyze codon positions of key mutations in the NS3 gene region of HCV genotype 3a.
- To investigate naturally occurring and treatment-induced resistance mutations in HCV NS3.
- To identify common mutation sites within the NS3 gene of prevalent Thai HCV strains.
Main Methods:
- Nucleotide sequencing and amino acid analysis of the NS3 gene region.
- Detection and confirmation of HCV genotype 3a.
- Clustering of sequenced samples into defined sub-clades (3a-1 and 3a-2).
Main Results:
- Twenty-six HCV genotype 3a samples were successfully sequenced.
- Amino acid variations were identified at multiple codon positions: 122 (3.8%), 132 (84.6%), 168 (100%), 170 (92.3%), 174 (100%), and 175 (100%).
- High prevalence of mutations at positions 168, 170, 174, and 175 was observed.
Conclusions:
- Mutations at NS3 positions 168, 170, 174, and 175 are frequently observed in HCV genotype 3a.
- Understanding these common mutations is crucial for designing effective DAAs.
- This research contributes to the development of improved therapies for HCV infection.
Background:
The hepatitis C virus (HCV) is a major cause of illness around the world. HCV genotype 3a is the most prevalent genotype in Thailand. Direct-acting antiviral (DAA) drugs are available for treatment, and these drugs target the NS3, NS5A, and NS5b proteins of HCV. However, HCV variants that are resistant to NS3 protease inhibitors have been found during treatment. This resistance can be naturally occurring or in response to treatment. The purpose of this study is to analyze the codon positions of the main mutation of the partial NS3 gene region of HCV genotype 3a.
Methods:
In order to detect mutations and confirm the genotype of HCV genotype 3a, the nucleotide sequencing and amino acid portion of NS3 were analyzed.
Results:
Twenty-six samples were successfully sequenced and clustered within two sub-clades defined as 3a-1 and 3a-2. Through amino acid mutation analysis, the variations were detected at codon positions 122 (3.8%), 132 (84.6%), 168 (100%), 170 (92.3%), 174 (100%), and 175 (100%).
Conclusions:
In conclusion, mutations at positions 168, 170, 174, and 175 of the NS3 region are common within the HCV genotype 3a. This information should be useful in the development of effective anti-viral drugs that can successfully treat HCV infection.
Related Concept Videos
01:25Hepatitis
01:28Viral Hepatitis I: Introduction